Cita APA

Puente, J., Campanario, R., Marmolejo, D., Cantero-Mellado, J., Gómez-Ferrer, A., Antolín, A., . . . Casas-Nebra, J. (2026). Treatment patterns in patients with castration-resistant prostate cancer who received darolutamide in the ARAMIS trial in Spain: PARASEC study.

Citación estilo Chicago

Puente, J., et al. Treatment Patterns in Patients With Castration-resistant Prostate Cancer Who Received Darolutamide in the ARAMIS Trial in Spain: PARASEC Study. 2026.

Cita MLA

Puente, J., et al. Treatment Patterns in Patients With Castration-resistant Prostate Cancer Who Received Darolutamide in the ARAMIS Trial in Spain: PARASEC Study. 2026.